Dr U'Prichard joins Ocimum's board
This article was originally published in Scrip
David U'Prichard, president of Druid Consulting LLC, has joined the board of Ocimum Biosolutions, a genomics solutions company in India. Dr U'Prichard holds board positions in several companies including Life Technologies, Oxagen, Cyclacel and Silence Therapeutics. He is also a partner at Red Abbey Venture Partners, and was chairman of R&D at SmithKline Beecham from 1997 to 1999, among other senior positions he has held in prior stints in the industry.
You may also be interested in...
Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…
Eisai and partner Sun to take lorcaserin off the Indian market. It remains to be seen whether the Japanese firm sees merit in pursuing a simmering patent infringement suit against Dr Reddy’s, which may need to review its own plans for lorcaserin.